Press Releases Molecular Templates, Inc.

Equities

MTEM

US6085502085

Delayed Nasdaq Other stock markets 03:42:40 2024-04-29 pm EDT			5-day change	1st Jan Change
1.715 ^USD	+0.59%		+14.33%	-54.02%

Apr. 12	Molecular Templates, Inc. Announces Cessation of Maurizio Voi as Chief Medical Officer, Effective April 30, 2024	CI
Apr. 09	Molecular Templates, Inc. Presents Interim Data from Mt-6402 Phase I Study in Patients with Pd-L1+ Solid Tumors At the 2024 American Association for Cancer Research Annual Meeting	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Molecular Templates Presents Interim Data from MT-6402 Phase I Study in Patients with PD-L1+ Solid Tumors at the 2024 American Association for Cancer Research (AACR) Annual Meeting; Monotherapy Activity in Checkpoint-Experienced Head and Neck Cancer Patients Observed Through Novel Immuno-oncology Mechanism	Apr. 09	AQ
Molecular Templates, Inc. Reports Fourth Quarter 2023 Financial Results and Business Update	Mar. 29	AQ
Molecular Templates Announces $9.5 Million Private Placement Offering and Agreement to Amend Second Tranche of July 2023 Purchase Agreement	Mar. 28	AQ
Molecular Templates, Inc. Provides Interim Update	Mar. 04	AQ
Molecular Templates to Present at Oppenheimer 34th Annual Healthcare Life Sciences Conference	Feb. 08	AQ
Molecular Templates, Inc. Reports Third Quarter 2023 Financial Results and Business Update	Nov. 13	AQ
Molecular Templates Announces First Patient Dosed in Phase 1 Trial Evaluating MT-8421, a Novel Engineered Toxin Body Targeting CTLA-4, in Advanced Solid Tumors	Nov. 02	AQ
Molecular Templates to Participate in Upcoming Investor Conferences	Nov. 01	AQ
Molecular Templates Announces the Appointment of Dr. Maurizio Voi to the Role of Chief Medical Officer	23-09-28	AQ
Molecular Templates Announces 1-for-15 Reverse Stock Split	23-08-11	AQ
Molecular Templates, Inc. Reports Second Quarter 2023 Financial Results and Business Update	23-08-10	AQ
Molecular Templates Announces Executive Leadership Changes	23-08-02	AQ
Molecular Templates Announces Up to $40 Million Private Placement Offering	23-07-13	AQ
MOLECULAR TEMPLATES, INC. : Other Events, Financial Statements and Exhibits (form 8-K)	23-06-20	AQ
Molecular Templates Announces Debt Payoff and Restructuring	23-06-19	AQ
Molecular Templates Announces Debt Payoff and Restructuring	23-06-16	AQ
MOLECULAR TEMPLATES, INC. : Other Events (form 8-K)	23-06-01	AQ
Molecular Templates Announces the FDA Removal of Partial Clinical Hold in the Phase 1 Clinical Trial for MT-0169 and Focuses on Extramedullary Myeloma	23-06-01	AQ
Molecular Templates to Present on Phase I Dose Escalation Study of MT-6402 at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting	23-05-26	AQ
Molecular Templates, Inc. Reports First Quarter 2023 Financial Results and Business Update	23-05-15	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Molecular Templates, Inc.

Equities

MTEM

US6085502085

Press Releases

Filters